The latest market report published by Credence Research, Inc. “Global Cell Surface Markers Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global cell surface markers market was valued at US$ 16,586.7 Mn in 2017, and is expected to reach US$ 33,712.7 Mn by 2026, expanding at a CAGR of 8.2% from 2018 to 2026.
According to research findings of the World Health Organization (WHO) by 2020, chronic diseases will account for three quarters of worldwide deaths. Cell surface markers are proteins expressed on the surface of cells that are useful for the identification of a cell type. Cell surface markers are present for B lymphocytes, T lymphocytes and differentiation clusters (CD34+, CD4, CD19, etc.).
Improved spending on the production of cell surface markers for drug discovery & growth and the burgeoning need to reduce the costs of disease diagnosis drive the market for cell surface markers. The limitations associated with the market for cell surface markers are complex products and expensive instruments and reagents used in cell marker analysis.
Reagents and kits have a stronghold in the market for cell surface markers as they are widely used to study cell signaling pathways and microscopic cellular functions. Flow cytometers are widely used by cell surface markers to identify hematopoietic stem cell populations such as CD 19, 20, 4 and CD34+ in the biological sample to understand cell migration in diabetes and cardiovascular disease.
Cell surface markers are commonly used in drug discovery and production worldwide for genomic research in the current scenario. Diagnosis of the disease will show impressive growth throughout the forecast period, taking into account key parameters such as increasing prevalence of chronic diseases and increasing public health awareness.
Diagnostic laboratories dominate the end-user market as pathologists use cell surface markers extensively in forensic and clinical investigations. Cell surface markers are used by prospective academic researchers to understand the etiology of chronic idiopathic diseases and to develop novel medicines for their treatment.
In the current scenario, North America dominates the market for cell surface markers due to key factors such as increasing demand for drug discovery and disease diagnosis. The presence of well-developed medical services and a growing awareness of nutrition in the diagnosis and treatment of chronic diseases are driving market growth in North America. Asia Pacific will see good growth during the forecast period due to the increasing number of diagnostic laboratories and proactive government initiatives to set up new research centers and academia.
The major players dominating the cell surface markers market are Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., F.Hoffman La-Roche AG, Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation and Thermo Fischer Scientific, Inc.
Key Market Movements:
- Increasing demand for development of targeted drug delivery and stem cell research
- Rising application for cell surface markers in diagnostic laboratories and research & academia
- Growing health awareness and development of healthcare infrastructure to drive the cell surface markers market